Sweet outcome for a rare inflammatory condition
Sweet syndrome is a rare inflammatory condition that was first described by Douglas Sweet in 1964 as an acute febrile neutrophilic dermatosis. It can be associated with infections, inflammatory conditions,pregnancy, drugs, and malignancy. It is usually divided into three subtypes based on etiology:...
Gespeichert in:
Veröffentlicht in: | New Zealand medical journal 2016-02, Vol.129 (1430), p.89-93 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 93 |
---|---|
container_issue | 1430 |
container_start_page | 89 |
container_title | New Zealand medical journal |
container_volume | 129 |
creator | Jalil, Salah Abdel Abdul-Kafi, Owais Smith, James Jalil, Ala' A Abdel |
description | Sweet syndrome is a rare inflammatory condition that was first described by Douglas Sweet in 1964 as an acute febrile neutrophilic dermatosis. It can be associated with infections, inflammatory conditions,pregnancy, drugs, and malignancy. It is usually divided into three subtypes based on etiology: classical(idiopathic); malignancy-associated; and drug-induced. We describe a patient with classical Sweet syndrome who had a dramatic response to corticosteroids.Our patient met the major criteria for diagnosis (positive histopathology and an abrupt onset of a painful rash), along with 4 minor criteria (fever, preceding upper respiratory tract infection, dramatic response to steroids, and leukocytosis). |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1768564543</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1768564543</sourcerecordid><originalsourceid>FETCH-LOGICAL-p154t-e938743e38f58e92a015c0220b2f686ae873c8128ed04ff262d7d4c2d1828b3e3</originalsourceid><addsrcrecordid>eNpd0EtLxDAUBeAgiDOO_gUJuHFTzDvpUgZfMOBCXZc0uYEOTTMmKTL_3oLjxtXdfOdwuGdoTamWjdFUrdBlKXtCmJQtuUArploqBJNrdP_-DVBxmqtLEXBIGVucbQY8TGG0Mdqa8hG7NPmhDmm6QufBjgWuT3eDPp8eP7Yvze7t-XX7sGsOVIraQMuNFhy4CdJAyyyh0hHGSM-CMsqC0dwZygx4IkJginnthWOeGmb6JbdBd7-9h5y-Zii1i0NxMI52gjSXjmplpBJS8IXe_qP7NOdpWbcoTQUxRKpF3ZzU3Efw3SEP0eZj9_cK_gPfjFb2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1771408056</pqid></control><display><type>article</type><title>Sweet outcome for a rare inflammatory condition</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Jalil, Salah Abdel ; Abdul-Kafi, Owais ; Smith, James ; Jalil, Ala' A Abdel</creator><creatorcontrib>Jalil, Salah Abdel ; Abdul-Kafi, Owais ; Smith, James ; Jalil, Ala' A Abdel</creatorcontrib><description>Sweet syndrome is a rare inflammatory condition that was first described by Douglas Sweet in 1964 as an acute febrile neutrophilic dermatosis. It can be associated with infections, inflammatory conditions,pregnancy, drugs, and malignancy. It is usually divided into three subtypes based on etiology: classical(idiopathic); malignancy-associated; and drug-induced. We describe a patient with classical Sweet syndrome who had a dramatic response to corticosteroids.Our patient met the major criteria for diagnosis (positive histopathology and an abrupt onset of a painful rash), along with 4 minor criteria (fever, preceding upper respiratory tract infection, dramatic response to steroids, and leukocytosis).</description><identifier>EISSN: 1175-8716</identifier><identifier>PMID: 26914425</identifier><language>eng</language><publisher>New Zealand: Pasifika Medical Association Group (PMAG)</publisher><subject>Anti-Inflammatory Agents - therapeutic use ; Female ; Humans ; Middle Aged ; Prednisone - therapeutic use ; Sweet Syndrome - drug therapy ; Sweet Syndrome - pathology</subject><ispartof>New Zealand medical journal, 2016-02, Vol.129 (1430), p.89-93</ispartof><rights>Copyright New Zealand Medical Association (NZMA) Feb 19, 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26914425$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jalil, Salah Abdel</creatorcontrib><creatorcontrib>Abdul-Kafi, Owais</creatorcontrib><creatorcontrib>Smith, James</creatorcontrib><creatorcontrib>Jalil, Ala' A Abdel</creatorcontrib><title>Sweet outcome for a rare inflammatory condition</title><title>New Zealand medical journal</title><addtitle>N Z Med J</addtitle><description>Sweet syndrome is a rare inflammatory condition that was first described by Douglas Sweet in 1964 as an acute febrile neutrophilic dermatosis. It can be associated with infections, inflammatory conditions,pregnancy, drugs, and malignancy. It is usually divided into three subtypes based on etiology: classical(idiopathic); malignancy-associated; and drug-induced. We describe a patient with classical Sweet syndrome who had a dramatic response to corticosteroids.Our patient met the major criteria for diagnosis (positive histopathology and an abrupt onset of a painful rash), along with 4 minor criteria (fever, preceding upper respiratory tract infection, dramatic response to steroids, and leukocytosis).</description><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Female</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Prednisone - therapeutic use</subject><subject>Sweet Syndrome - drug therapy</subject><subject>Sweet Syndrome - pathology</subject><issn>1175-8716</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpd0EtLxDAUBeAgiDOO_gUJuHFTzDvpUgZfMOBCXZc0uYEOTTMmKTL_3oLjxtXdfOdwuGdoTamWjdFUrdBlKXtCmJQtuUArploqBJNrdP_-DVBxmqtLEXBIGVucbQY8TGG0Mdqa8hG7NPmhDmm6QufBjgWuT3eDPp8eP7Yvze7t-XX7sGsOVIraQMuNFhy4CdJAyyyh0hHGSM-CMsqC0dwZygx4IkJginnthWOeGmb6JbdBd7-9h5y-Zii1i0NxMI52gjSXjmplpBJS8IXe_qP7NOdpWbcoTQUxRKpF3ZzU3Efw3SEP0eZj9_cK_gPfjFb2</recordid><startdate>20160219</startdate><enddate>20160219</enddate><creator>Jalil, Salah Abdel</creator><creator>Abdul-Kafi, Owais</creator><creator>Smith, James</creator><creator>Jalil, Ala' A Abdel</creator><general>Pasifika Medical Association Group (PMAG)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AYAGU</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20160219</creationdate><title>Sweet outcome for a rare inflammatory condition</title><author>Jalil, Salah Abdel ; Abdul-Kafi, Owais ; Smith, James ; Jalil, Ala' A Abdel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p154t-e938743e38f58e92a015c0220b2f686ae873c8128ed04ff262d7d4c2d1828b3e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Female</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Prednisone - therapeutic use</topic><topic>Sweet Syndrome - drug therapy</topic><topic>Sweet Syndrome - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jalil, Salah Abdel</creatorcontrib><creatorcontrib>Abdul-Kafi, Owais</creatorcontrib><creatorcontrib>Smith, James</creatorcontrib><creatorcontrib>Jalil, Ala' A Abdel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Australia & New Zealand Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>New Zealand medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jalil, Salah Abdel</au><au>Abdul-Kafi, Owais</au><au>Smith, James</au><au>Jalil, Ala' A Abdel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sweet outcome for a rare inflammatory condition</atitle><jtitle>New Zealand medical journal</jtitle><addtitle>N Z Med J</addtitle><date>2016-02-19</date><risdate>2016</risdate><volume>129</volume><issue>1430</issue><spage>89</spage><epage>93</epage><pages>89-93</pages><eissn>1175-8716</eissn><abstract>Sweet syndrome is a rare inflammatory condition that was first described by Douglas Sweet in 1964 as an acute febrile neutrophilic dermatosis. It can be associated with infections, inflammatory conditions,pregnancy, drugs, and malignancy. It is usually divided into three subtypes based on etiology: classical(idiopathic); malignancy-associated; and drug-induced. We describe a patient with classical Sweet syndrome who had a dramatic response to corticosteroids.Our patient met the major criteria for diagnosis (positive histopathology and an abrupt onset of a painful rash), along with 4 minor criteria (fever, preceding upper respiratory tract infection, dramatic response to steroids, and leukocytosis).</abstract><cop>New Zealand</cop><pub>Pasifika Medical Association Group (PMAG)</pub><pmid>26914425</pmid><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1175-8716 |
ispartof | New Zealand medical journal, 2016-02, Vol.129 (1430), p.89-93 |
issn | 1175-8716 |
language | eng |
recordid | cdi_proquest_miscellaneous_1768564543 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Anti-Inflammatory Agents - therapeutic use Female Humans Middle Aged Prednisone - therapeutic use Sweet Syndrome - drug therapy Sweet Syndrome - pathology |
title | Sweet outcome for a rare inflammatory condition |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T10%3A18%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sweet%20outcome%20for%20a%20rare%20inflammatory%20condition&rft.jtitle=New%20Zealand%20medical%20journal&rft.au=Jalil,%20Salah%20Abdel&rft.date=2016-02-19&rft.volume=129&rft.issue=1430&rft.spage=89&rft.epage=93&rft.pages=89-93&rft.eissn=1175-8716&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1768564543%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1771408056&rft_id=info:pmid/26914425&rfr_iscdi=true |